Shionogi locks in global rights to OncoTherapy's peptide vaccines
This article was originally published in Scrip
Executive Summary
Shionogi has built on its existing licensing alliances with OncoTherapy Science (OTS) to strike a deal that gives it worldwide rights to all future peptide vaccines discovered by the Japanese bioventure.